Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunityImmunology Brief Research Report Published on 2024-05-172024-09-05 Journal: Frontiers in immunology [Category] update2024, [키워드] AZD1222 (ChaAdOx1 nCoV-19) COVID-19 COVID-19 vaccination Cross-immunity human coronaviruses humoral responses SARS-CoV-2 seasonal coronavirus [DOI] 10.3389/fimmu.2024.1401728 PMC 바로가기 [Article Type] Immunology Brief Research Report
Evaluation of Cellular Responses to ChAdOx1-nCoV-19 and BNT162b2 VaccinationsArticle Published on 2023-05-012023-07-11 Journal: Annals of laboratory medicine [Category] COVID19(2023년), [키워드] Cellular responses humoral responses immunogenicity severe acute respiratory syndrome coronavirus 2 vaccination [DOI] 10.3343/alm.2023.43.3.290 PMC 바로가기
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccineReport Published on 2023-01-092024-09-05 Journal: Cell Reports [Category] update2024, [키워드] B cell responses coronavirus COVID-19 humoral responses Hybrid immunity neutralization Omicron subvariants SARS-CoV-2 spike glycoproteins third mRNA vaccine dose [DOI] 10.1016/j.celrep.2023.111998 PMC 바로가기 [Article Type] Report
Risk of waning humoral responses after inactivated or subunit recombinant SARS‐CoV‐2 vaccination in patients with chronic diseases: Findings from a prospective observational study in ChinaResearch Article Published on 2023-01-042024-09-05 Journal: Journal of medical virology [Category] update2024, [키워드] COVID‐19 humoral responses SARS‐CoV‐2 Vaccine [DOI] 10.1002/jmv.28434 PMC 바로가기 [Article Type] Research Article
Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccinationArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] Anti-spike Antibody Response B cell B cell responses BBIBP-CorV booster booster vaccination CD4 CD8 comparable COVID-19 COVID-19 vaccines de novo demonstrated detectable dramatic increase Epidemic exhibited Features humoral immune response Humoral immunity humoral responses interferon-γ Neutralizing antibodies omicron remained S protein SARS-CoV-2 SARS-COV-2 infection serotype Severe case Shanghai significantly T cell T cell response T cell responses T cell responses. Th1 cytokine vaccination vaccinee vaccinees wild type [DOI] 10.1080/22221751.2022.2130101 PMC 바로가기
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesArticle Published on 2022-10-252022-11-15 Journal: Cell Reports [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome Administering boost caused coronavirus COVID-19 CP: Immunology Donor dose elicit elicited extended interval humoral Humoral response humoral responses individual Infection long interval mRNA vaccine observé omicron regimen robust SARS-CoV-2 SARS-CoV-2 BNT162b2 second dose significantly spike glycoproteins third mRNA vaccine dose vaccinated individuals variant variants of concern VoC VOCs [DOI] 10.1016/j.celrep.2022.111554 PMC 바로가기
A systematic review and meta-analysis of the IgA seroprevalence in COVID-19 patients: Is there a role for IgA in COVID-19 diagnosis or severity?COVID-19 환자의 IgA 혈청 유병률에 대한 체계적인 검토 및 메타 분석: COVID-19 진단 또는 중증도에서 IgA의 역할이 있습니까?Meta-Analysis Published on 2022-10-012022-09-11 Journal: Microbiological research [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, 치료기술, [키워드] Abstract acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody association asymptomatic patients Biomarker caused coronavirus coronavirus disease COVID-19 COVID-19 diagnosis COVID-19 disease determine diagnostic diagnostic test diagnostic tests disease Efficacy Health health problems Humoral response humoral responses IgA Immunity in some include Infection manuscript Meta-analysis Mild observé Patient problems produced Research respiratory SARS-CoV-2 SARS-CoV-2 PCR Seroprevalence severe acute respiratory syndrome Coronavirus Severe patient severe patients severity susceptibility symptomatic systematic review Vaccines [DOI] 10.1016/j.micres.2022.127105 PMC 바로가기 [Article Type] Meta-Analysis
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third DoseArticle Published on 2022-09-212022-11-15 Journal: The Journal of Infectious Diseases [Category] SARS, 진단, [키워드] ACE2 ACE2 displacement acute respiratory syndrome Adults age antibody concentration benefit binding binding antibodies chronic health condition chronic health conditions circulating antibody comparable coronavirus coronavirus disease COVID-19 COVID-19 mRNA vaccines COVID-19 vaccine domain dose doses exceeded functional humoral Humoral immunity Humoral response humoral responses immune immunogenicity data less magnitude mount mRNA Older Older adults omicron reached response Result SARS-CoV-2 Spike protein strain Strong Vaccine vaccine dose vaccine doses viral neutralization Virus neutralization [DOI] 10.1093/infdis/jiac199 PMC 바로가기
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyCOVID-19 백신 접종 후 항-CD20 치료 환자의 강력한 T-세포 반응: 전향적 코호트 연구Observational Study Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus anti-CD20 anti-CD20 therapy anti-CD20 treatment antibodies antibody Antibody Response Arthritis Breakthrough infection CD20 CD4 CD4 T cell CD8 T cell CD8 T cells cohort study Complication Control controls coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine detectable dose Effectiveness effector molecule effector molecules expressed Follow-up had no humoral humoral responses individual Mild mRNA COVID-19 vaccines mRNA-based COVID-19 vaccine multiple sclerosis Ocrelizumab Patient patients treated Prospective prospective observational cohort reduction respiratory response response rate response rates rheumatic disease Rheumatic diseases rheumatoid arthritis risk rituximab seroconverted severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe coronavirus disease severe COVID-19 significantly lower specific antibodies spike T cell T cells T-cell T-cell Response T-cell responses Th1 phenotype treated treated patient vaccination [DOI] 10.1093/cid/ciab954 PMC 바로가기 [Article Type] Observational Study
T cell perturbations persist for at least 6 months following hospitalization for COVID-19T 세포 교란은 COVID-19로 입원한 후 최소 6개월 동안 지속됩니다.Article Published on 2022-08-082022-09-11 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료법, [키워드] addition affected alteration anti-Nucleocapsid IgG antibody Arm CD4 CD57 CD69 CD8 Cell consequence convalescence COVID-19 COVID-19 pathogenesis COVID-19 patient COVID-19 patients dependent on elevated event expressing flow cytometry follicular Hospitalization Humoral response humoral responses IgG immune immune cells immune system Immunity Inclusion marker Neutralizing Neutralizing antibodies neutralizing antibody responses Pathogenesis Perturbation Population populations SARS-CoV-2 spectral flow cytometry. study duration sustained symptom onset T cell T cell activation T cell impairment T cell responses T cell subsets T cells T helper TEMRA the disease upregulated with COVID-19 [DOI] 10.3389/fimmu.2022.931039 PMC 바로가기 [Article Type] Article